ACICLOVIR DEMOGEN (Demogen Australia Pty Ltd trading as DEMOGEN Pharmaceuticals)

ACICLOVIR DEMOGEN powder for injection is indicated for the purpose of:

1. Promoting resolution of acute clinical manifestations of mucocutaneous Herpes simplex virus infections in immunocompromised patients.
2. Treatment of severe first episode primary or non-primary genital herpes in immune competent patients.
3. Treatment of acute manifestations of Varicella zoster virus infection in immunocompromised patients.
4. Treatment of shingles (Varicella zoster virus infection) in immune competent patients who show very severe acute local or systemic manifestations of the disease. Benefits can be expected in patients with rash duration shorter than 72 hours. The use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients with shingles.
5. Treatment of Herpes simplex encephalitis.